Improving Virtual Care of Arthritis: Integrating a Smartphone App Into the EHR for Improved Timeliness of Visits (RAPID-PsA)
Arthritis, Psoriatic Arthritis
About this trial
This is an interventional supportive care trial for Arthritis focused on measuring Arthritis, Psoriatic Arthritis, Mobile Health
Eligibility Criteria
Inclusion Criteria: Be diagnosed with PsA by a board-certified rheumatologist and been seen at least twice in the prior year Own a smartphone with either an Android or iPhone operating system Be at least 18 years old Be English-speaking Using guselkumab, infliximab, golimumab or ustekinumab Exclusion Criteria: Patients who do not plan on receiving follow-up care at the Brigham and Women's Arthritis Center will be excluded.
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Experimental
No Intervention
Mobile Application
Controls
This arm of the study will contain half the study population after randomization. The participants in this arm will receive the EHR integrated app and follow a 12-month interrupted time series analysis (ITSA) design. n = 200
This arm of the study will contain half the study population after randomization. The participants in this arm will be from the same rheumatologists as the experimental participants and will be used as concurrent controls by accessing their data on visits from the EHR during the same time period. n = 200